Rheumatoid factor does not predict response to TNF antagonists in rheumatoid arthritis: three centers experience.

作者信息

Salgado Eva, Campos José, Moreira-Navarrete Virginia, Mulero Juan, Navarro Federico, Pérez-Pampín Eva, Carmona Loreto, Gómez-Reino Juan

出版信息

Joint Bone Spine. 2013 Jul;80(4):438-40. doi: 10.1016/j.jbspin.2013.01.004. Epub 2013 Mar 1.

DOI:10.1016/j.jbspin.2013.01.004

PMID:23453477

Abstract

摘要

相似文献

Rheumatoid factor does not predict response to TNF antagonists in rheumatoid arthritis: three centers experience.

Joint Bone Spine. 2013 Jul;80(4):438-40. doi: 10.1016/j.jbspin.2013.01.004. Epub 2013 Mar 1.

Rheumatoid factor appearance after tocilizumab treatment seems to predict bad therapeutical response in rheumatoid arthritis.托珠单抗治疗后类风湿因子的出现似乎预示着类风湿关节炎的治疗反应不佳。

Rheumatol Int. 2013 Jul;33(7):1909-10. doi: 10.1007/s00296-012-2409-1. Epub 2012 Mar 24.

Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: systematic review and meta-analysis of observational studies.类风湿因子与肿瘤坏死因子拮抗剂治疗类风湿关节炎的反应：观察性研究的系统评价和荟萃分析。

Joint Bone Spine. 2014 Jan;81(1):41-50. doi: 10.1016/j.jbspin.2013.04.004. Epub 2013 Jun 2.

[Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFalpha agents failed are associated with response to rituximab in rheumatoid arthritis].类风湿因子阳性而非抗环瓜氨酸肽抗体阳性、较低的残疾程度以及较少的抗TNFα药物治疗失败与类风湿关节炎患者对利妥昔单抗的反应相关。

Reumatismo. 2009 Jul-Sep;61(3):182-6. doi: 10.4081/reumatismo.2009.182.

Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis.治疗前血清干扰素-β/α 比值升高预示类风湿关节炎患者对肿瘤坏死因子α抑制治疗无反应。

Ann Rheum Dis. 2016 Oct;75(10):1757-62. doi: 10.1136/annrheumdis-2015-208001. Epub 2015 Nov 6.

High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis.高IgA类风湿因子水平与类风湿关节炎患者对肿瘤坏死因子α抑制剂的临床反应不佳相关。

Ann Rheum Dis. 2007 Mar;66(3):302-7. doi: 10.1136/ard.2006.060608. Epub 2006 Nov 1.

High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study.类风湿关节炎患者基线时类风湿因子和抗 CCP 抗体的高滴度与循环基线 TNF 水平升高、药物水平低和临床反应降低有关：对 RISING 研究的事后分析。

Arthritis Res Ther. 2017 Sep 2;19(1):194. doi: 10.1186/s13075-017-1401-2.

Escalated conventional therapy for rheumatoid arthritis patients.类风湿关节炎患者的强化传统治疗

Rheumatology (Oxford). 2004 Sep;43(9):1199; author reply 1199-1200. doi: 10.1093/rheumatology/keh291.

Association of anti-CCP positivity and carriage of TNFRII susceptibility variant with anti-TNF-α response in rheumatoid arthritis.抗环瓜氨酸肽抗体阳性和肿瘤坏死因子受体 II 易感性变异与类风湿关节炎患者对 TNF-α 拮抗剂反应的相关性。

Clin Exp Rheumatol. 2011 Jul-Aug;29(4):701-4. Epub 2011 Sep 1.

Identification of cartilage oligomeric matrix protein as biomarker predicting abatacept response in rheumatoid arthritis patients with insufficient response to a first anti-TNFα treatment.鉴定软骨寡聚基质蛋白作为预测对首次抗TNFα治疗反应不足的类风湿关节炎患者阿巴西普反应的生物标志物。

Joint Bone Spine. 2019 May;86(3):401-403. doi: 10.1016/j.jbspin.2018.09.005. Epub 2018 Sep 19.

引用本文的文献

Rheumatoid factors revisited in the age of biologic therapy.生物治疗时代对类风湿因子的再审视。

Rheumatology (Oxford). 2025 Mar 1;64(Supplement_2):ii15-ii24. doi: 10.1093/rheumatology/keaf035.

Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis.类风湿关节炎中因疗效不佳导致肿瘤坏死因子抑制剂停药与血清阳性的相关性。

Clin Rheumatol. 2019 Oct;38(10):2757-2763. doi: 10.1007/s10067-019-04626-x. Epub 2019 Jun 10.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验